Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT00313820
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2006-04-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-10
First Submit QC Date:
None
Study First Post Date:
2006-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-09-08
Results First Submit QC Date:
None
Results First Post Date:
2009-10-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-21
Last Update Post Date:
2021-02-09
Last Update Post Date Type:
ACTUAL